Page 5 - Viral Vector News Today

Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing: Global Strategic Business Report" report has been added to ...

Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene therapies, today formally inaugurates its new manufacturing headquarters, the Andelyn Corporate Center (ACC), located in the Innovation District in Columbus, Ohio.

Orgenesis and University of California, Davis sign partnership agreement for rollout of cell and gene therapy mobile processing units and labs throughout California Germantown, Maryland and Davis, California, US, June 7, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company&r...

/PRNewswire/ -- What is the Overview of Cell and Gene Therapy CDMO Market? Cell and gene therapies (CAGT) are used in treating various diseases like heart...

Forecasts by Process (Upstream Process, Downstream Process), by Downstream Process (Fill and Finish Operations, Analytical and QC Studies, Vaccine...

Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand.

Cell-Easy SAS ("Cell-Easy"), a rapidly growing Contract Development and Manufacturing Organization ("CDMO") that specializes in cell therapy, has appointed Dr. Sebastien Ribault, PhD, to its board

TOULOUSE, France--(BUSINESS WIRE)--Cell-Easy SAS (“Cell-Easy”), a rapidly growing Contract Development and Manufacturing Organization (“CDMO”) that specializes in cell therapy, has appointed Dr. Sebastien Ribault, PhD, to its board of directors, to further accelerate its growth.Cell-Easy is a leading contract develo...

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market - A Global and Regional Analysis: Focus on Chemical Synthesis...

Researchers discuss the challenges impeding the development of vaccines against flaviviruses.